According to Evofem Biosciences 's latest financial reports and stock price the company's current Operating Margin is -499.63%. At the end of 2021 the company had an Operating Margin of -2,488.78%.
Year | Operating Margin | Change |
---|---|---|
2021 | -2,488.78% | -92.2% |
2020 | -31,906.95% | |
2012 | -7,827.62% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -36.36% | -92.72% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -8,391.15% | 1,579.47% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.